Breaking Down Chongqing Fuling Zhacai Group Co., Ltd. Financial Health: Key Insights for Investors

CN | Consumer Defensive | Packaged Foods | SHZ

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) is a buy, hold or avoid? Start here: in Q1 2025 the company posted revenue of CNY 713.01 million (down from CNY 748.6 million a year earlier) and trailing twelve-month revenue of CNY 2.42 billion (a 1.52% decline year-over-year), while market capitalization sits at CNY 14.69 billion with a P/S of 6.36; profitability shows Q1 net income of CNY 272.27 million and a TTM net margin of 33.86% with EPS at CNY 0.69, yet EBITDA fell 4.20% in Q1 and free cash flow was negative CNY 154.04 million-offset by a robust balance sheet of CNY 9.52 billion in assets, CNY 8.89 billion in equity and CNY 6.25 billion in cash (decreased 3.68%), low leverage with a debt-to-equity of 0.07, but a worrying jump in accounts receivable to CNY 120.88 million (+1,375%); valuation metrics include a P/E of 18.44, forward P/E of 16.83, dividend yield of 3.30% (CNY 0.42/share) and a beta of 0.78-read on for granular analysis of revenue drivers (South China contributes CNY 650.6 million or 27% of sales), liquidity, risks from declining revenue trends and AR growth, and the growth initiatives that management is banking on.

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Revenue Analysis

Chongqing Fuling Zhacai Group's recent top-line trajectory shows consecutive annual declines and soft quarterly performance into 2025. Key figures and segment contributions highlight where revenue pressure is concentrated and the scale of operations relative to market valuation.

  • Q1 2025 revenue: CNY 713.01 million (down from CNY 748.6 million in Q1 2024)
  • TTM revenue (as of 2025-09-30): CNY 2.42 billion (decline of 1.52% year-over-year)
  • Revenue growth: -2.56% in 2024; -3.86% in 2023 - negative growth for three consecutive years
  • Primary segment: South China revenue CNY 650.6 million, representing 27% of total revenue
  • Workforce and productivity: 2,768 employees; revenue per employee ≈ CNY 875,450
  • Market valuation (2025-12-12): market cap CNY 14.69 billion; P/S ratio 6.36
Metric Value Period / Note
Q1 Revenue CNY 713.01 million Q1 2025
Q1 Revenue (prior year) CNY 748.6 million Q1 2024
TTM Revenue CNY 2.42 billion As of 2025-09-30
Revenue growth (2024) -2.56% Annual
Revenue growth (2023) -3.86% Annual
South China segment CNY 650.6 million 27% of total revenue
Employees 2,768 Headcount
Revenue per employee CNY 875,450 TTM revenue / employees (approx.)
Market capitalization CNY 14.69 billion As of 2025-12-12
Price-to-Sales (P/S) 6.36 Based on market cap (2025-12-12) / TTM revenue
  • Revenue trend: three-year negative growth signals structural or demand challenges rather than a one-off quarter dip.
  • Concentration risk: South China alone accounts for more than a quarter of sales (CNY 650.6 million), implying geographic exposure.
  • Productivity and scale: revenue per employee (~CNY 875,450) provides a benchmark for operational efficiency versus peers.
  • Valuation context: a P/S of 6.36 with declining revenue raises valuation premium considerations relative to growth prospects.

Further context on strategic positioning and corporate direction is available here: Mission Statement, Vision, & Core Values (2026) of Chongqing Fuling Zhacai Group Co., Ltd.

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Profitability Metrics

Key profitability indicators for Chongqing Fuling Zhacai Group show stability in absolute earnings but modest softness in margin and per-share metrics through the trailing twelve months ending September 30, 2025 and the first quarter of 2025.

Metric Value (Period) Comparison / Notes
Net Income CNY 272.27 million (Q1 2025) Slightly above CNY 271.63 million (Q1 2024)
Net Profit Margin 33.86% (TTM ending 2025-09-30) Down from 34.00% (2024)
Earnings Per Share (EPS) CNY 0.69 (TTM) Down from CNY 0.72 (2023)
Return on Assets (ROA) 5.84% Indicates moderate asset efficiency
Return on Capital (ROC) 6.24% Measured return on invested capital
Effective Tax Rate 15.10% (Q1 2025) Relatively low statutory/effective tax burden
EBITDA CNY 246.75 million (Q1 2025) Down 4.20% vs Q1 2024
  • Net income stability: Q1 2025 net income of CNY 272.27M vs CNY 271.63M year-on-year - minimal change suggests steady top-line and cost control offsetting margin pressure.
  • Margin trend: Net profit margin slipped from 34.00% to 33.86% TTM, signaling slight margin compression that investors should monitor for persistence.
  • EPS decline: EPS fell to CNY 0.69 (TTM) from CNY 0.72 in 2023 - impact on per-share returns likely from lower comprehensive profitability or dilution effects.
  • Operating cash proxy: EBITDA decreased 4.20% YoY in Q1 2025 to CNY 246.75M, pointing to softer operating performance or higher operating expenses.
  • Capital efficiency: ROA 5.84% and ROC 6.24% - moderate returns relative to asset and capital base; useful when benchmarking against peers in packaged/food condiments sector.
  • Tax profile: Effective tax rate of 15.10% (Q1 2025) supports after-tax profitability compared with higher statutory rates.

For additional context on the company's background, ownership and business model, see Chongqing Fuling Zhacai Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Debt vs. Equity Structure

As of September 30, 2025, Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) displays a capital structure characterized by a dominant equity base and minimal leverage. Key balance-sheet metrics illustrate strong capitalization and substantial liquidity, while select working-capital items show notable movement year-over-year.

  • Total assets: CNY 9.52 billion (as of 2025-09-30)
  • Total liabilities: CNY 629.45 million (as of 2025-09-30)
  • Total equity: CNY 8.89 billion (as of 2025-09-30)
  • Debt-to-equity ratio: ~0.07 (629.45M / 8.89B)
  • Cash & short-term investments: CNY 6.25 billion (down 3.68% YoY)
  • Cash growth rate (past 12 months): -3.69%
  • Accounts receivable: CNY 120.88 million (up from CNY 8.19 million in 2024)
Metric Amount (CNY) Notes / YoY Change
Total Assets 9,520,000,000 As of 2025-09-30
Total Liabilities 629,450,000 As of 2025-09-30
Total Equity 8,890,550,000 As of 2025-09-30
Debt-to-Equity Ratio 0.07 Low financial leverage
Cash & Short-Term Investments 6,250,000,000 Decrease of 3.68% YoY
Cash Growth Rate (12 months) -3.69% Negative cash growth
Accounts Receivable 120,880,000 Up from 8,190,000 in 2024

The combination of CNY 8.89 billion in equity and CNY 629.45 million in liabilities yields a capitalization profile where shareholders' equity overwhelmingly funds the business; leverage remains low at roughly 0.07. Liquidity is sizable with CNY 6.25 billion in cash and equivalents, though cash has contracted slightly year-over-year. The sharp increase in accounts receivable from CNY 8.19 million to CNY 120.88 million warrants attention for working-capital trends and collection risk.

Additional context on the company's background and business model can be found here: Chongqing Fuling Zhacai Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Liquidity and Solvency

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) presents a liquidity profile characterized by strong cash holdings and low leverage, which supports both short-term obligations and operational resilience.

  • Current ratio: not directly disclosed but inferred to be healthy given substantial cash reserves relative to short-term liabilities.
  • Quick ratio: not directly disclosed but likely solid because cash and short-term investments form a large share of current assets, reducing reliance on inventory.
  • Operating cash flow (Q1 2025): CNY 322.96 million, down 0.71% year-over-year.
  • Free cash flow (Q1 2025): CNY -154.04 million, a decline of 341.60% year-over-year.
  • Net change in cash (Q1 2025): CNY 233.72 million, up 265.12% year-over-year.
  • Cash conversion cycle: not published but inferred efficient given low debt and substantial cash buffers.
Metric Q1 2025 YoY Change
Operating Cash Flow CNY 322.96 million -0.71%
Free Cash Flow CNY -154.04 million -341.60%
Net Change in Cash CNY 233.72 million +265.12%

Key implications for investors:

  • Positive operating cash flow near prior levels indicates ongoing operational cash generation despite a small decline.
  • The sharp swing in free cash flow to negative primarily reflects increased capital expenditure or working-capital investments in the quarter; monitor capex and receivables/inventory trends in subsequent quarters.
  • The material increase in net cash change improves the company's immediate liquidity position and provides flexibility for debt servicing, reinvestment, or dividends.
  • Low reported debt levels combined with significant cash reserves reduce solvency risk, supporting creditor confidence and strategic optionality.

For background on the company's broader strategy and ownership context, see: Chongqing Fuling Zhacai Group Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Valuation Analysis

Key market valuation metrics for Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) as of 12 December 2025 provide a snapshot of how the market prices the business versus earnings, book value and sales, while indicating income return and relative volatility.

Metric Value
Price-to-Earnings (P/E) 18.44
Forward P/E 16.83
Dividend per share (CNY) 0.42
Dividend yield 3.30%
Ex-dividend date 2025-06-04
Payment date 2025-06-04
Market capitalization CNY 14.69 billion
Price-to-Sales (P/S) 6.36
Price-to-Book (P/B) 1.70
Beta (3y) 0.78
  • P/E of 18.44 vs. forward P/E 16.83 indicates expected earnings growth or analyst upgrades priced in for the next 12 months.
  • P/B at 1.70 signals a moderate premium to book value - neither deep value nor extreme overvaluation on a book basis.
  • P/S of 6.36 reflects a relatively high revenue multiple, implying investors pay a premium for revenue-generating capacity or margin expectations.
  • Dividend yield 3.30% with CNY 0.42 per share provides a meaningful income component; ex-dividend and payment both on 2025-06-04 indicate a single cash distribution date.
  • Beta 0.78 suggests lower volatility than the broader market; useful for portfolio risk allocation and income-focused investors.

Practical investor considerations:

  • Income investors: 3.30% yield combined with a stable payout date may be attractive if payout sustainability (coverage ratios, free cash flow) is verified.
  • Value vs growth trade-off: Forward P/E compression versus current P/E warrants checking analyst earnings revisions and growth drivers.
  • Relative valuation: Compare P/E, P/B and P/S to domestic peers in packaged food/condiment sector to assess premium/discount.

For further background on shareholder composition and recent investor activity, see: Exploring Chongqing Fuling Zhacai Group Co., Ltd. Investor Profile: Who's Buying and Why?

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Risk Factors

  • Trailing twelve-month revenue decline: -1.52% (ending 2025-09-30)
  • Accounts receivable surge: +1,375% year-over-year - potential liquidity and credit-collection stress
  • Negative free cash flow: CNY 154.04 million in Q1 2025 - pressure on funding operations and capex
  • EBITDA contraction: -4.20% in Q1 2025 vs Q1 2024 - margin and profitability deterioration
  • Geographic concentration: South China segment contributes 27% of total revenue - exposure to regional economic swings
  • Product diversification risk: revenue from 'other products' down 26% in 2024 vs 2023
Metric Value Period / Comparison
Revenue growth (TTM) -1.52% Trailing twelve months ending 2025-09-30
Accounts receivable change +1,375% Year-over-year (most recent fiscal year)
Free cash flow -CNY 154.04 million Q1 2025
EBITDA change -4.20% Q1 2025 vs Q1 2024
Revenue concentration: South China 27% Share of total revenue
Revenue from other products -26% 2024 vs 2023
  • Liquidity and working-capital risk: the 1,375% rise in receivables combined with negative FCF in Q1 2025 suggests strained cash conversion and heightened counterparty/credit risk.
  • Profitability risk: EBITDA down 4.20% year-on-year in Q1 signals margin pressure that may worsen if cost inflation or pricing pressure continues.
  • Concentration risk: reliance on South China (27% of revenue) increases sensitivity to regional demand cycles, policy shifts, or supply-chain disruptions.
  • Product mix risk: a 26% decline in revenue from other products in 2024 undermines diversification and may reduce resilience to core-market volatility.
  • Funding and investment constraints: persistent negative free cash flow could force reliance on external financing, dilutive equity issuance, or deferral of strategic investments.
Exploring Chongqing Fuling Zhacai Group Co., Ltd. Investor Profile: Who's Buying and Why?

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) - Growth Opportunities

  • Announced cash dividend: CNY 2 per 10 shares for H1 2025, total payout CNY 230 million - signal of strong cash flow and shareholder returns.
  • New catering division established; active collaborations with multiple hotels and well-known chain restaurants to open recurring B2B/B2C revenue streams.
  • Product portfolio adjustments: launch of new SKUs (e.g., radish line) contributing to portfolio refresh; radish revenue declined 24.44% in 2024 vs. 2023 despite being positioned as growth driver.
  • Other-business segment expanded: revenue up 9.53% in 2024 vs. prior year, pointing to successful diversification beyond core preserved vegetable products.
  • Company-led marketing initiatives and dealer network optimization aimed at improving channel efficiency, brand presence and sell-through.
Metric Value / Change Implication
H1 2025 Dividend CNY 2 per 10 shares; total CNY 230,000,000 Cash return; signals liquidity and capital allocation discipline
Radish product revenue (2024 vs 2023) -24.44% Weakness in specific SKU despite product launch; needs marketing/channel support
Other business revenue (2024 vs 2023) +9.53% Positive diversification; incremental contribution to top line
Expansion into other areas (2024 growth) +9.53% Shows traction outside core preserved-vegetable operations
Catering division Partnerships with hotels & chain restaurants (multiple) New recurring B2B revenue channel; cross-selling potential
  • Near-term growth levers: monetizing catering partnerships, accelerating marketing support for new SKUs (radish), and scaling the "other business" vertical.
  • Execution risks: reviving radish sales (-24.44% in 2024), converting partnerships into stable margins, and maintaining cash generation while funding expansion.
  • Investor signals to watch: dividend sustainability (CNY 230M H1 2025), quarterly trends in other-business revenue, channel inventory turnover, and marketing ROI.
Exploring Chongqing Fuling Zhacai Group Co., Ltd. Investor Profile: Who's Buying and Why?

DCF model

Chongqing Fuling Zhacai Group Co., Ltd. (002507.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.